You just read:

Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia

News provided by

Sangamo BioSciences, Inc.

Feb 04, 2015, 07:00 ET